<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD05500000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P25116</UniProt_ID>
  <Seq_Length>425</Seq_Length>
  <Molecule_Weight>47441</Molecule_Weight>
  <KEGG_ID>hsa:2149</KEGG_ID>
  <Orthology_ID>K03914</Orthology_ID>
  <EBI_ID>EBI-2803960</EBI_ID>
  <Function_Summary>High affinity receptor for activated thrombin coupled to G proteins that stimulate phosphoinositide hydrolysis. May play a role in platelets activation and in vascular development.</Function_Summary>
  <Pfam_ID>PF00001:7tm_1</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>69</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Coagulation factor II receptor</Alias>
      <Alias>Thrombin receptor</Alias>
      <Alias>PAR-1</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Combining with thrombin to initiate a G-protein mediated change in cell activity. A G-protein is a signal transduction molecule that alternates between an inactive GDP-bound and an active GTP-bound state.</Detail>
      <Keyword>Thrombin receptor activity</Keyword>
      <Ontology_ID>GO:0015057</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a G-protein beta subunit.</Detail>
      <Keyword>G-protein beta-subunit binding</Keyword>
      <Ontology_ID>GO:0031681</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with an extracellular or intracellular messenger to initiate a change in cell activity.</Detail>
      <Keyword>Receptor activity</Keyword>
      <Ontology_ID>GO:0004872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a G-protein alpha subunit. The alpha subunit binds a guanine nucleotide.</Detail>
      <Keyword>G-protein alpha-subunit binding</Keyword>
      <Ontology_ID>GO:0001965</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.</Detail>
      <Keyword>Receptor binding</Keyword>
      <Ontology_ID>GO:0005102</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>187</Position>
      <Original>Tyr</Original>
      <Variation>Asn</Variation>
    </Muntion>
    <Muntion>
      <Position>257</Position>
      <Original>Val</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>268</Position>
      <Original>Ala</Original>
      <Variation>Pro</Variation>
    </Muntion>
    <Muntion>
      <Position>335</Position>
      <Original>Ala</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>166</Position>
      <Original>Ser</Original>
      <Variation>Gly</Variation>
    </Muntion>
    <Muntion>
      <Position>412</Position>
      <Original>Ser</Original>
      <Variation>Tyr</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate, or extent of interleukin-1 beta production.</Detail>
      <Keyword>Regulation of interleukin-1 beta production</Keyword>
      <Ontology_ID>GO:0032651</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the release into the cytosolic compartment of calcium ions sequestered in the endoplasmic reticulum or mitochondria.</Detail>
      <Keyword>Positive regulation of release of sequestered calcium ion into cytosol</Keyword>
      <Ontology_ID>GO:0051281</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The initiation of the activity of the inactive enzyme MAP kinase kinase by phosphorylation by a MAPKKK.</Detail>
      <Keyword>Activation of MAPKK activity</Keyword>
      <Ontology_ID>GO:0000186</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.</Detail>
      <Keyword>Response to lipopolysaccharide</Keyword>
      <Ontology_ID>GO:0032496</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which anatomical structures are generated and organized. Morphogenesis pertains to the creation of form.</Detail>
      <Keyword>Anatomical structure morphogenesis</Keyword>
      <Ontology_ID>GO:0009653</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of an I-kappaB kinase/NF-kappaB induced cascade.</Detail>
      <Keyword>Positive regulation of I-kappaB kinase/NF-kappaB cascade</Keyword>
      <Ontology_ID>GO:0043123</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of introducing a phosphate group to a tyrosine residue of a STAT (Signal Transducer and Activator of Transcription) protein.</Detail>
      <Keyword>Tyrosine phosphorylation of STAT protein</Keyword>
      <Ontology_ID>GO:0007260</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of vasoconstriction.</Detail>
      <Keyword>Positive regulation of vasoconstriction</Keyword>
      <Ontology_ID>GO:0045907</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the concentration of calcium ions in the cytosol that contributes to the process of G-protein signaling coupled to IP3 second messenger.</Detail>
      <Keyword>Elevation of cytosolic calcium ion concentration involved in G-protein signaling coupled to IP3 second messenger</Keyword>
      <Ontology_ID>GO:0051482</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents or reduces the rate or extent of cell proliferation.</Detail>
      <Keyword>Negative regulation of cell proliferation</Keyword>
      <Ontology_ID>GO:0008285</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.</Detail>
      <Keyword>G-protein coupled receptor protein signaling pathway</Keyword>
      <Ontology_ID>GO:0007186</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The series of events leading to growth of connective tissue when loss of tissues that are incapable of regeneration occurs, or when fibrinous exudate cannot be adequately cleared that contribute to an inflammatory response.</Detail>
      <Keyword>Connective tissue replacement involved in inflammatory response wound healing</Keyword>
      <Ontology_ID>GO:0002248</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.</Detail>
      <Keyword>Hemostasis</Keyword>
      <Ontology_ID>GO:0007599</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.</Detail>
      <Keyword>Blood coagulation</Keyword>
      <Ontology_ID>GO:0007596</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The initiation of the activity of the inactive enzyme protein kinase C as the result of a series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.</Detail>
      <Keyword>Activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway</Keyword>
      <Ontology_ID>GO:0007205</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal, e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light, and ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell, and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.</Detail>
      <Keyword>Signal transduction</Keyword>
      <Ontology_ID>GO:0007165</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of Rho protein signal transduction.</Detail>
      <Keyword>Positive regulation of Rho protein signal transduction</Keyword>
      <Ontology_ID>GO:0035025</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of blood coagulation.</Detail>
      <Keyword>Positive regulation of blood coagulation</Keyword>
      <Ontology_ID>GO:0030194</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of dimerized STAT (Signal Transducers and Activators of Transcription) proteins into the nucleus following activation by members of the janus activated kinase (JAK) family of tyrosine kinases.</Detail>
      <Keyword>STAT protein import into nucleus</Keyword>
      <Ontology_ID>GO:0007262</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Upregulation of the activity of a caspase, any of a group of cysteine proteases involved in apoptosis.</Detail>
      <Keyword>Activation of caspase activity</Keyword>
      <Ontology_ID>GO:0006919</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.</Detail>
      <Keyword>Platelet activation</Keyword>
      <Ontology_ID>GO:0030168</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.</Detail>
      <Keyword>Positive regulation of phosphatidylinositol 3-kinase cascade</Keyword>
      <Ontology_ID>GO:0014068</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the rate or extent of cell proliferation.</Detail>
      <Keyword>Positive regulation of cell proliferation</Keyword>
      <Ontology_ID>GO:0008284</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the sensory perception of pain, the series of events required for an organism to receive a painful stimulus, convert it to a molecular signal, and recognize and characterize the signal.</Detail>
      <Keyword>Regulation of sensory perception of pain</Keyword>
      <Ontology_ID>GO:0051930</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of smooth muscle contraction.</Detail>
      <Keyword>Positive regulation of smooth muscle contraction</Keyword>
      <Ontology_ID>GO:0045987</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of collagen, any of a group of fibrous proteins of very high tensile strength that form the main component of connective tissue in animals.</Detail>
      <Keyword>Positive regulation of collagen biosynthetic process</Keyword>
      <Ontology_ID>GO:0032967</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which calcium ions sequestered in the endoplasmic reticulum or mitochondria are released into the cytosolic compartment.</Detail>
      <Keyword>Release of sequestered calcium ion into cytosol</Keyword>
      <Ontology_ID>GO:0051209</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of glomerular filtration. Glomerular filtration is the processs whereby blood is filtered by the glomerulus into the renal tubule.</Detail>
      <Keyword>Negative regulation of glomerular filtration</Keyword>
      <Ontology_ID>GO:0003105</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of the JAK-STAT signaling pathway activity.</Detail>
      <Keyword>Positive regulation of JAK-STAT cascade</Keyword>
      <Ontology_ID>GO:0046427</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of cellular DNA-dependent transcription.</Detail>
      <Keyword>Positive regulation of transcription, DNA-dependent</Keyword>
      <Ontology_ID>GO:0045893</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptosis in neurons.</Detail>
      <Keyword>Negative regulation of neuron apoptosis</Keyword>
      <Ontology_ID>GO:0043524</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of cell migration.</Detail>
      <Keyword>Positive regulation of cell migration</Keyword>
      <Ontology_ID>GO:0030335</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The biological process in which a synapse between a motor neuron and a muscle is initially formed.</Detail>
      <Keyword>Establishment of synaptic specificity at neuromuscular junction</Keyword>
      <Ontology_ID>GO:0007529</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a platelet dense granule. A platelet dense granule is an electron-dense granule occurring in blood platelets that stores and secretes adenosine nucleotides and serotonin. They contain a highly condensed core consisting of serotonin, histamine, calcium, magnesium, ATP, ADP, pyrophosphate and membrane lysosomal proteins.</Detail>
      <Keyword>Platelet dense granule organization</Keyword>
      <Ontology_ID>GO:0060155</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any biological process involved in the maintenance of the steady-state number of cells within a population of cells in a tissue.</Detail>
      <Keyword>Homeostasis of number of cells within a tissue</Keyword>
      <Ontology_ID>GO:0048873</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.</Detail>
      <Keyword>Positive regulation of ERK1 and ERK2 cascade</Keyword>
      <Ontology_ID>GO:0070374</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <molStructure/>
  <Molecule_Seq>
    <Protein_Seq>MGPRRLLLVAACFSLCGPLLSARTRARRPESKATNATLDPRSFLLRNPNDKYEPFWEDEEKNESGLTEYRLVSINKSSPLQKQLPAFISEDASGYLTSSWLTLFVPSVYTGVFVVSLPLNIMAIVVFILKMKVKKPAVVYMLHLATADVLFVSVLPFKISYYFSGSDWQFGSELCRFVTAAFYCNMYASILLMTVISIDRFLAVVYPMQSLSWRTLGRASFTCLAIWALAIAGVVPLLLKEQTIQVPGLNITTCHDVLNETLLEGYYAYYFSAFSAVFFFVPLIISTVCYVSIIRCLSSSAVANRSKKSRALFLSAAVFCIFIICFGPTNVLLIAHYSFLSHTSTTEAAYFAYLLCVCVSSISCCIDPLIYYYASSECQRYVYSILCCKESSDPSSYNSSGQLMASKMDTCSSNLNNSIYKKLLT</Protein_Seq>
    <DNA_Seq>AGAGACTCTCACTGCACGCCGGAGGGCGCCCTTCCTCGCTCGCGCCCGCGCGACCGCGCGCCCCAGTCCCGCCCCGCCCCGCTAACCGCCCCAGACACAGCGCTCGCCGAGGGTCGCTTGGACCCTGATCTTACCCGTGGGCACCCTGCGCTCTGCCTGCCGCGAAGACCGGCTCCCCGACCCGCAGAAGTCAGGAGAGAGGGTGAAGCGGAGCAGCCCGAGGCGGGGCAGCCTCCCGGAGCAGCGCCGCGCAGAGCCCGGGACAATGGGGCCGCGGCGGCTGCTGCTGGTGGCCGCCTGCTTCAGTCTGTGCGGCCCGCTGTTGTCTGCCCGCACCCGGGCCCGCAGGCCAGAATCAAAAGCAACAAATGCCACCTTAGATCCCCGGTCATTTCTTCTCAGGAACCCCAATGATAAATATGAACCATTTTGGGAGGATGAGGAGAAAAATGAAAGTGGGTTAACTGAATACAGATTAGTCTCCATCAATAAAAGCAGTCCTCTTCAAAAACAACTTCCTGCATTCATCTCAGAAGATGCCTCCGGATATTTGACCAGCTCCTGGCTGACACTCTTTGTCCCATCTGTGTACACCGGAGTGTTTGTAGTCAGCCTCCCACTAAACATCATGGCCATCGTTGTGTTCATCCTGAAAATGAAGGTCAAGAAGCCGGCGGTGGTGTACATGCTGCACCTGGCCACGGCAGATGTGCTGTTTGTGTCTGTGCTCCCCTTTAAGATCAGCTATTACTTTTCCGGCAGTGATTGGCAGTTTGGGTCTGAATTGTGTCGCTTCGTCACTGCAGCATTTTACTGTAACATGTACGCCTCTATCTTGCTCATGACAGTCATAAGCATTGACCGGTTTCTGGCTGTGGTGTATCCCATGCAGTCCCTCTCCTGGCGTACTCTGGGAAGGGCTTCCTTCACTTGTCTGGCCATCTGGGCTTTGGCCATCGCAGGGGTAGTGCCTCTGCTCCTCAAGGAGCAAACCATCCAGGTGCCCGGGCTCAACATCACTACCTGTCATGATGTGCTCAATGAAACCCTGCTCGAAGGCTACTATGCCTACTACTTCTCAGCCTTCTCTGCTGTCTTCTTTTTTGTGCCGCTGATCATTTCCACGGTCTGTTATGTGTCTATCATTCGATGTCTTAGCTCTTCCGCAGTTGCCAACCGCAGCAAGAAGTCCCGGGCTTTGTTCCTGTCAGCTGCTGTTTTCTGCATCTTCATCATTTGCTTCGGACCCACAAACGTCCTCCTGATTGCGCATTACTCATTCCTTTCTCACACTTCCACCACAGAGGCTGCCTACTTTGCCTACCTCCTCTGTGTCTGTGTCAGCAGCATAAGCTGCTGCATCGACCCCCTAATTTACTATTACGCTTCCTCTGAGTGCCAGAGGTACGTCTACAGTATCTTATGCTGCAAAGAAAGTTCCGATCCCAGCAGTTATAACAGCAGTGGGCAGTTGATGGCAAGTAAAATGGATACCTGCTCTAGTAACCTGAATAACAGCATATACAAAAAGCTGTTAACTTAGGAAAAGGGACTGCTGGGAGGTTAAAAAGAAAAGTTTATAAAAGTGAATAACCTGAGGATTCTATTAGTCCCCACCCAAACTTTATTGATTCACCTCCTAAAACAACAGATGTACGACTTGCATACCTGCTTTTTATGGGAGCTGTCAAGCATGTATTTTTGTCAATTACCAGAAAGATAACAGGACGAGATGACGGTGTTATTCCAAGGGAATATTGCCAATGCTACAGTAATAAATGAATGTCACTTCTGGATATAGCTAGGTGACATATACATACTTACATGTGTGTATATGTAGATGTATGCACACACATATATTATTTGCAGTGCAGTATAGAATAGGCACTTTAAAACACTCTTTCCCCGCACCCCAGCAATTATGAAAATAATCTCTGATTCCCTGATTTAATATGCAAAGTCTAGGTTGGTAGAGTTTAGCCCTGAACATTTCATGGTGTTCATCAACAGTGAGAGACTCCATAGTTTGGGCTTGTACCACTTTTGCAAATAAGTGTATTTTGAAATTGTTTGACGGCAAGGTTTAAGTTATTAAGAGGTAAGACTTAGTACTATCTGTGCGTAGAAGTTCTAGTGTTTTCAATTTTAAACATATCCAAGTTTGAATTCCTAAAATTATGGAAACAGATGAAAAGCCTCTGTTTTGATATGGGTAGTATTTTTTACATTTTACACACTGTACACATAAGCCAAAACTGAGCATAAGTCCTCTAGTGAATGTAGGCTGGCTTTCAGAGTAGGCTATTCCTGAGAGCTGCATGTGTCCGCCCCCGATGGAGGACTCCAGGCAGCAGACACATGCCAGGGCCATGTCAGACACAGATTGGCCAGAAACCTTCCTGCTGAGCCTCACAGCAGTGAGACTGGGGCCACTACATTTGCTCCATCCTCCTGGGATTGGCTGTGAACTGATCATGTTTATGAGAAACTGGCAAAGCAGAATGTGATATCCTAGGAGGTAATGACCATGAAAGACTTCTCTACCCATCTTAAAAACAACGAAAGAAGGCATGGACTTCTGGATGCCCATCCACTGGGTGTAAACACATCTAGTAGTTGTTCTGAAATGTCAGTTCTGATATGGAAGCACCCATTATGCGCTGTGGCCACTCCAATAGGTGCTGAGTGTACAGAGTGGAATAAGACAGAGACCTGCCCTCAAGAGCAAAGTAGATCATGCATAGAGTGTGATGTATGTGTAATAAATATGTTTCACACAAACAAGGCCTGTCAGCTAAAGAAGTTTGAACATTTGGGTTACTATTTCTTGTGGTTATAACTTAATGAAAACAATGCAGTACAGGACATATATTTTTTAAAATAAGTCTGATTTAATTGGGCACTATTTATTTACAAATGTTTTGCTCAATAGATTGCTCAAATCAGGTTTTCTTTTAAGAATCAATCATGTCAGTCTGCTTAGAAATAACAGAAGAAAATAGAATTGACATTGAAATCTAGGAAAATTATTCTATAATTTCCATTTACTTAAGACTTAATGAGACTTTAAAAGCATTTTTTAACCTCCTAAGTATCAAGTATAGAAAATCTTCATGGAATTCACAAAGTAATTTGGAAATTAGGTTGAAACATATCTCTTATCTTACGAAAAAATGGTAGCATTTTAAACAAAATAGAAAGTTGCAAGGCAAATGTTTATTTAAAAGAGCAGGCCAGGCGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCGGGTGGATCACGAGGTCAGGAGATCGAGACCATCCTGGCTAACACGGTGAAACCCGTCTCTACTAAAAATGCAAAAAAAATTAGCCGGGCGTGGTGGCAGGCACCTGTAGTCCCAGCTACTCGGGAGGCTGAGGCAGGAGACTGGCGTGAACCCAGGAGGCGGACCTTGTAGTGAGCCGAGATCGCGCCACTGTGCTCCAGCCTGGGCAACAGAGCAAGACTCCATCTCAAAAAATAAAAATAAATAAAAAATAAAAAAATAAAAGAGCAAACTATTTCCAAATACCATAGAATAACTTACATAAAAGTAATATAACTGTATTGTAAGTAGAAGCTAGCACTGGTTTTATTAATTTAGTGACTATTCATTTTATCTAAATCAGTGAAGATTTACTGTCATTGTTTATTAGTCTGTATATATTAAAATATGATATCATTAATGTACTTACAAAATAGTATGTCACTGTTTTTATGTTCATTCTTAAAAACATAACCTGTATTAATAAATGTGAACATTTGCTTGGTAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Platelets</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Vascular endothelial cells</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Golgi apparatus</CellLocal>
      <Ontology_ID>GO:0005794</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Neuromuscular junction</CellLocal>
      <Ontology_ID>GO:0031594</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular region</CellLocal>
      <Ontology_ID>GO:0005576</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Platelet dense tubular network</CellLocal>
      <Ontology_ID>GO:0031094</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to plasma membrane</CellLocal>
      <Ontology_ID>GO:0005887</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Integral to membrane</CellLocal>
      <Ontology_ID>GO:0016021</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Caveola</CellLocal>
      <Ontology_ID>GO:0005901</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Postsynaptic membrane</CellLocal>
      <Ontology_ID>GO:0045211</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>F2R</Gene_Name>
    <Gene_Alias>CF2R; PAR1; TR</Gene_Alias>
    <Gene_ID>2149</Gene_ID>
    <Genbank_ACCN>NM_001992</Genbank_ACCN>
    <Protein_ACCN>NP_001983</Protein_ACCN>
    <HGNC_ID>3537</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/2149</Gene_URL>
    <UCSC_ID>uc003ken.4</UCSC_ID>
    <EMBL_ID>ENSG00000181104</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q03135</Uniprot_ID>
      <Gene_Name>CAV1</Gene_Name>
      <EBI_ID>EBI-603614</EBI_ID>
      <PPI_EBI_URL>EBI-2803960,EBI-603614</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q9UNN8</Uniprot_ID>
      <Gene_Name>PROCR</Gene_Name>
      <EBI_ID>EBI-719705</EBI_ID>
      <PPI_EBI_URL>EBI-2803960,EBI-719705</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Melanoma Metastasis</Disease_Name>
      <Disease_Detail>Melanoma</Disease_Detail>
      <Disease_DB>MLN013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/melanoma_metastasis?search=F2R#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Bernard-Soulier Syndrome</Disease_Name>
      <Disease_Detail>Bernard-Soulier Syndrome</Disease_Detail>
      <Disease_DB>BRN019</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/bernard_soulier_syndrome?search=F2R#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>5q- Syndrome</Disease_Name>
      <Disease_Detail>5q- Syndrome</Disease_Detail>
      <Disease_DB>5QS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/5q_syndrome?search=F2R#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Glanzmann's Thrombasthenia</Disease_Name>
      <Disease_Detail>Glanzmann's Thrombasthenia</Disease_Detail>
      <Disease_DB>GLN003</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/glanzmanns_thrombasthenia?search=F2R#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES</PDB_Title>
      <PDB_ID>1NRP</PDB_ID>
      <Resolution>3.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NRP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes.</PubMed_Title>
      <Author>Mathews, I.I., et al.</Author>
      <Journal>Biochemistry(1994)33:3266-3279</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8136362?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human thrombin mutant S195A in complex with the extracellular fragment of human PAR1</PDB_Title>
      <PDB_ID>3LU9</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3LU9</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of thrombin bound to the uncleaved extracellular fragment of PAR1.</PubMed_Title>
      <Author>Gandhi, P.S., et al.</Author>
      <Journal>J.Biol.Chem.(2010)285:15393-15398</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20236938?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES</PDB_Title>
      <PDB_ID>1NRN</PDB_ID>
      <Resolution>3.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NRN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes.</PubMed_Title>
      <Author>Mathews, I.I., et al.</Author>
      <Journal>Biochemistry(1994)33:3266-3279</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8136362?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystallographic structures of Thrombin complexed with Thrombin receptor peptides: Existence of expected and novel binding modes</PDB_Title>
      <PDB_ID>1NRR</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NRR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes.</PubMed_Title>
      <Author>Mathews, I.I., et al.</Author>
      <Journal>Biochemistry(1994)33:3266-3279</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8136362?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of thrombin bound to the extracellular fragment of PAR1</PDB_Title>
      <PDB_ID>3BEF</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3BEF</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural identification of the pathway of long-range communication in an allosteric enzyme.</PubMed_Title>
      <Author>Gandhi, P.S., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.Usa(2008)105:1832-1837</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18250335?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of human thrombin mutant W215A/E217A in complex with the extracellular fragment of human PAR1</PDB_Title>
      <PDB_ID>3HKJ</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3HKJ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Mechanism of the Anticoagulant Activity of Thrombin Mutant W215A/E217A.</PubMed_Title>
      <Author>Gandhi, P.S., et al.</Author>
      <Journal>J.Biol.Chem.(2009)284:24098-24105</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19586901?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of murine thrombin mutant W215A/E217A in complex with the extracellular fragment of human PAR1</PDB_Title>
      <PDB_ID>3HKI</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3HKI</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Mechanism of the Anticoagulant Activity of Thrombin Mutant W215A/E217A.</PubMed_Title>
      <Author>Gandhi, P.S., et al.</Author>
      <Journal>J.Biol.Chem.(2009)284:24098-24105</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/19586901?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES</PDB_Title>
      <PDB_ID>1NRQ</PDB_ID>
      <Resolution>3.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NRQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes.</PubMed_Title>
      <Author>Mathews, I.I., et al.</Author>
      <Journal>Biochemistry(1994)33:3266-3279</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8136362?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES</PDB_Title>
      <PDB_ID>1NRO</PDB_ID>
      <Resolution>3.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1NRO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes.</PubMed_Title>
      <Author>Mathews, I.I., et al.</Author>
      <Journal>Biochemistry(1994)33:3266-3279</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/8136362?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05200</Pathway_ID>
      <Pathway_Title>Pathways in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04611</Pathway_ID>
      <Pathway_Title>Platelet activation</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04610</Pathway_ID>
      <Pathway_Title>Complement and coagulation cascades</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04810</Pathway_ID>
      <Pathway_Title>Regulation of actin cytoskeleton</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cell motility</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04024</Pathway_ID>
      <Pathway_Title>cAMP signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04080</Pathway_ID>
      <Pathway_Title>Neuroactive ligand-receptor interaction</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signaling molecules and interaction</Pathway_Subclass>
    </Network>
  </Network_List>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>domain,Helix 8</Site_Detail>
      <Site_Reference>Dowal L, et al. Proc Natl Acad Sci U S A. 2011,108(7):2951-2956.</Site_Reference>
      <PubMed_ID>21282664</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD05503001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503013</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503015</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503016</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503017</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503018</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503019</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503020</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503021</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503022</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503023</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503024</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503025</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503026</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503027</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503028</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503029</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503030</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503031</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503032</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503033</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503034</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503035</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503036</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503037</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503038</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503039</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503040</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503041</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503042</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503043</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503044</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503045</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503046</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503047</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503048</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503049</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503050</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503051</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503052</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503053</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503054</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503055</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503056</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503057</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503058</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503059</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503060</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503061</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503062</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503063</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503064</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503065</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503066</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503067</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503068</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD05503069</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>